India Drug Makers, Associations Unite In Challenge To New Pricing Rules
This article was originally published in PharmAsia News
Executive Summary
Several India drug makers and organizations are ready to join Alembic, Cipla and others in judicial challenges of a days-old regulation giving drug makers 45 days to replace their stocks with lower-priced drugs.